SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
| pages: 1 2 3
|
presentations:
1 to
50 of
116
|
CROI Program Committee Chair Welcome to Wednesday
Nicolas Chomont
Université de Montréal, Montreal, Canada
Long COVID: Causes, Consequences, and the Way Forward (ABSTRACT
41)
Roger Paredes
IrsiCaixa, Badalona, Spain
Weight Gain in People With HIV (ABSTRACT
42)
Jordan E. Lake
University of Texas Health Science Center at Houston, Houston, TX, USA
Introduction of Speakers Part 1
Major Improvement in Age-Related Health Outcomes in People Living With HIV: An 18-Year Cohort Study (ABSTRACT
175)
Alejandro Garcia
Hospital Ramón y Cajal, Madrid, Spain
Early vs Deferred HIV Therapy and Cardiovascular Disease in People With HIV: The START Study (ABSTRACT
176)
Nila J. Dharan
University of New South Wales Sydney, Sydney, Australia
Epidemiology of Coronary Atherosclerosis Among People Living With HIV in Uganda (ABSTRACT
177)
Mark J. Siedner
Massachusetts General Hospital, Boston, MA, USA
Plaque, Inflammation, Subclinical Myocardial Injury, and MACE in the REPRIEVE Mechanistic Substudy (ABSTRACT
178)
Steven Grinspoon
Massachusetts General Hospital, Boston, MA, USA
Questions and Answers Part 1
Introduction of Speakers Part 2
Frailty Is Associated With Higher MACE Incidence but Does Not Appear to Modify Pitavastatin Effects (ABSTRACT
179)
Kristine M. Erlandson
University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Prognostic Value of Epigenetic Age Acceleration in People With Well-Controlled HIV Infection (ABSTRACT
180)
Patricia Martínez-Martín
La Paz University Hospital, Madrid, Spain
Semaglutide Stabilizes Epigenetic Aging in People With HIV-Associated Lipohypertrophy (ABSTRACT
181)
Michael J. Corley
Weill Cornell Medicine, New York, NY, USA
Letermovir for CMV Suppression Improves Immunologic and Functional Aging Outcomes in Treated HIV (ABSTRACT
182)
Sara Gianella Weibel
University of California San Diego, La Jolla, CA, USA
Questions and Answers Part 2
Introduction of Speakers Part 1
Long-Acting Cabotegravir PrEP Uptake and Persistence in a Large US Healthcare System (ABSTRACT
191)
Michael Traeger
Harvard Pilgrim Health Care Institute, Boston, MA, USA
ImPrEP CAB Brasil: Enhancing PrEP Coverage With CAB-LA in Young Key Populations (ABSTRACT
192)
Beatriz Grinsztejn
Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
Estimation of Prevention-Effective CAB-LA Concentrations Among MSM/TGW in HPTN 083 (ABSTRACT
193)
Brett S. Hanscom
Fred Hutchinson Cancer Center, Seattle, WA, USA
Adherence to F/TAF in Cisgender Women Prevents HIV With Low Risk of Resistance or Diagnostic Delay (ABSTRACT
194)
Flavia M. Kiweewa
Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda
Questions and Answers Part 1
Introduction of Speakers Part 2
Performance of HIV RNA Screening in the Context of Long-Acting Injectable Cabotegravir in HPTN 084 (ABSTRACT
195)
Sinead Delany-Moretlwe
University of the Witwatersrand, Johannesburg, South Africa
PILLAR Month 12 Clinical Results: Zero HIV Acquisition and High Persistence With CAB LA for PrEP (ABSTRACT
196)
Taimur Khan
Fenway Health, Boston, MA, USA
Response to HIV Treatment After Long-Acting Cabotegravir Preexposure Prophylaxis in HPTN 083 (ABSTRACT
197)
Raphael J. Landovitz
University of California Los Angeles, Los Angeles, CA, USA
An Injectable Multipurpose Implant With CAB and MPA for Long-Acting HIV Prevention and Contraception (ABSTRACT
199)
S. Rahima Benhabbour
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Questions and Answers Part 2
Introduction of Speakers Part 1
Preliminary Efficacy for HPTN 094: 26-Week RCT of Integrated Strategies for People Who Inject Drugs (ABSTRACT
183)
Steve Shoptaw
University of California Los Angeles, Los Angeles, CA, USA
Most With HIV Viremia Are Not in Care Despite High ART Coverage: A Population-Based Study in Uganda (ABSTRACT
184)
Silas Odiya
Rakai Health Sciences Program, Kalisizo, Uganda
Low-Cost Counseling Achieves Positive Outcomes for Malawi Men Disengaged From Care: Randomized Trial (ABSTRACT
185)
Kathryn L. Dovel
University of California Los Angeles, Los Angeles, CA, USA
Clinic Switching and Elevated HIV Viral Load in 6 African Countries: A Population-Based Study (ABSTRACT
186)
Joseph G. Rosen
Brown University, Providence, RI, USA
Questions and Answers Part 1
Introduction of Speakers Part 2
How Do Repeated Financial Incentives Affect HIV Care-Seeking Behaviors Over Time? (ABSTRACT
187)
Solis Winters
University of California Berkeley, Berkeley, CA, USA
Effect of a Person-Centered Care Intervention on Reengagement After Care Interruptions in Zambia (ABSTRACT
188)
Aaloke Mody
Washington University in St Louis, St Louis, MO, USA
Systems Analysis and Improvement Approach to Optimize Hypertension Care for People Living With HIV (ABSTRACT
189)
Sarah Gimbel
University of Washington, Seattle, WA, USA
SEARCH Integrated HIV/Hypertension Community Health Worker-Led Intervention in Rural East Africa (ABSTRACT
190)
Matt Hickey
University of California San Francisco, San Francisco, CA, USA
Questions and Answers Part 2
Introduction of Speakers Part 1
Brain Volume Normalization After 96 Weeks of ART Started During Acute HIV Infection (ABSTRACT
167)
Robert Paul
University of Missouri St Louis, St Louis, MO, USA
Spinal Cord as a Distinct Site of HIV Persistence and Dispersal in the Brain (ABSTRACT
168)
Mattia Trunfio
University of California San Diego, La Jolla, CA, USA
Longitudinal Persistence of HIV DNA in CSF Over 4 Years Despite Up to 20 Years of ART (ABSTRACT
169)
Joshua C. Cyktor
University of Pittsburgh, Pittsburgh, PA, USA
Questions and Answers Part 1
Introduction of Speakers Part 2
Plasma Phosphorylated Tau 217 and Cognitive Decline in Older Thai People With HIV (ABSTRACT
171)
Akarin Hiransuthikul
Chulalongkorn University, Bangkok, Thailand
Semaglutide Improves Cognitive Function in HIV, Effect Mediated by Decrease in Inflammation (ABSTRACT
172)
Ornina Atieh
Case Western Reserve University, Cleveland, OH, USA
Brain Gray and White Matter Alterations in Cognitive Long COVID (ABSTRACT
173)
Lindsay S. McAlpine
Yale University, New Haven, CT, USA
Structural Brain Volumes Decrease After SARS-CoV-2 Infection Among People With HIV (ABSTRACT
174)
Jacob Bolzenius
University of Missouri St Louis, St Louis, MO, USA
Questions and Answers Part 2
|
<< first | < prev
page:
of 3
|
records per page:
next >
| last >>
|
| pages: 1 2 3
|
presentations:
1 to
50 of
116
|
